William Sellers, DO
Surgery · Port Jefferson, NYNPI 1437411428
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 82.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $5,048 and has fallen 57.1% since, to $2,163 in 2025.
Across 162 payments — averaging $86.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- THD America, Inc.$727
- Medtronic$429
- Integra Lifesciences Corporation$263
- Novo Nordisk$250
- Innocoll Pharmaceuticals Limited$212
- plus $604 from 12 others
What the payments were for
- Travel & lodging$2,90421%
- Food & beverage$6,16844%
- Education$5,00036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 119 | $11,586 |
| THD America, Inc. | 5 | $727 |
| Medtronic | 4 | $429 |
| Integra Lifesciences Corporation | 7 | $263 |
| Novo Nordisk | 2 | $250 |
| Innocoll Pharmaceuticals Limited | 8 | $212 |
| Smith+Nephew | 4 | $167 |
| Enterra Medical, Inc. | 1 | $117 |
| Olympus America Inc. | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Kerecis Limited | 1 | $40 |
| TELA Bio, Inc. | 2 | $29 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| Merck | 1 | $18 |
| Bioventus LLC | 1 | $18 |
| Molnlycke Health Care US, LLC | 1 | $17 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,073 in reported general payments places this provider in the 85th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Proctofoam-HcHydrocortisone/Pramoxine | 20 | $3,532 |
| Hydrocortisone | 16 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $118 |
| Oxycodone Hcl | 20 | $96 |
Paid to pharmacies, not to this prescriber.
Other surgery in Port Jefferson
- Joseph PinkhasPort Jefferson$122K
- Hesham AtwaPort Jefferson$110K
- Ashish AgarwalaPort Jefferson$106K
- Arif AhmadPort Jefferson$60K
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Benjamin SadowitzSyracuse$419K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.